FLAMMA breaks ground for new R&D building in Italy

Chignolo D’Isola, Bergamo, Italy – May 21, 20209 – Flamma SpA (“Flamma”), a preeminent Contract Development and Manufacturing Organization (CDMO) that develops, manufactures, and commercializes small molecule Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry, is proud to announce the ground breaking for their new R&D building. While most CEOs use a gold plated shovel, Flamma’s CEO Gian Paolo Negrisoli, used an excavator to mark the groundbreaking of the new R&D Building at Flamma’s headquarters in Chignolo d’Isola, Bergamo, Italy.

This marks the expansion at Flamma’s headquarters that will allow Flamma to quadruple its R&D space. The R&D building will accommodate 50 additional employees providing additional R&D and analytical development laboratories as well as offices and meeting rooms. In addition to these features, there will be a lab for high containment and special chemistries.

During the Covid-19 crisis of 2020, our teams in Italy and China worked tirelessly to continue production of important molecules that are critical to help fight the virus. The Italian team hung a sign reading #MOLAMIA which means ‘Don’t Give Up’. Flamma doesn’t give up. This important milestone is another example of the commitment made to not only customers but employees to deliver a first class organization where people want to place their projects.

The new R&D building will serve as a complement the R&D work being done at Flamma USA in Malvern, PA outside of Philadelphia. The team in the USA continues to grow as more projects come on board. For further information, please visit the Flamma website at http://www.flammagroup.com.

View a one minute video here: https://vimeo.com/424568102